Case Reports

A ‘double-hit’ bone marrow rare co-occurrence of 2 different pathologies


 

Chronic myeloid leukemia and chronic lymphocytic leukemia are entirely different in terms of pathogenesis, presentation, diagnostic work-up, treatment, and prognosis: CML is a myeloproliferative condition, whereas CLL involves lymphoid population. Here we discuss a very rare case of co-occurrence of CML and CLL in the same patient.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

ICYMI: Elotuzumab reduces progression risk in lenalidomide-refractory multiple myeloma
MDedge Hematology and Oncology
FDA approves elotuzumab with pom/dex in refractory myeloma
MDedge Hematology and Oncology
Report details financial burden of blood cancers
MDedge Hematology and Oncology
FDA puts selinexor on fast track for DLBCL
MDedge Hematology and Oncology
Aberrant RNA editing linked to aggressive myeloma
MDedge Hematology and Oncology
P-BCMA-101 gains FDA regenerative medicine designation
MDedge Hematology and Oncology
Financial burden of blood cancers in the U.S.
MDedge Hematology and Oncology
FDA clears portable hematology analyzer
MDedge Hematology and Oncology
Selinexor on fast track for DLBCL
MDedge Hematology and Oncology
Combo appears safe, active in rel/ref NHL
MDedge Hematology and Oncology